Skip to main content
. Author manuscript; available in PMC: 2012 Sep 18.
Published in final edited form as: Int Immunopharmacol. 2011 May 1;11(9):1303–1310. doi: 10.1016/j.intimp.2011.04.013

Fig. 3. Comparison of CB2 WT and W194Y mutant receptors in agonist-induced inhibition of forskolin-stimulated cAMP accumulation.

Fig. 3

EC50 values were 5.91±4.87 nM for CB2 WT and 45.48±5.86 nM for W194Y treated with CP55940 (a), 7.49±3.85 nM for CB2 WT and 21.79±1.65 nM for W194Y mutant treated with WIN55212-2 (b). Data are mean ± S.E.M. of three independent experiments in triplicate.